by Site Dev | Oct 20, 2021 | Clinical Trials, Lymphoma
Lymphoma Clinical Trials Contact Us DIFFUSE LARGE B-CELL LYMPHOMA: (4) 1) 2ND line or greater/ SGN35-031: A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination with Lenalidomide...
